早產兒視網膜病變

10.6666/ClinMed.2017.79.4.037

彭韻純；蔡傑智

早產兒視網膜病變(retinopathy of prematurity) ； 雷射光凝固治療(laser photocoagulation) ； 抗血管內皮新生因子玻璃體內藥物注射術(intravitreal anti-vascular endothelial growth factor injection)

臨床醫學月刊

79卷4期（2017 / 04 / 28）

199 - 203

繁體中文

早產兒視網膜病變及其併發症是造成開發中及已開發國家中幼兒眼盲的重要原因。隨著醫療科技日新月異，新的篩檢工具和治療方式推陳出新，本文將介紹早產兒視網膜病變之疾病分期、危險因子、追蹤原則及治療選擇。未來仍需更大型的研究及長期追蹤，以期能達到預防疾病惡化、維持後續視力發展的可能性及避免嚴重併發症發生的治療目的。

1. (1984).An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity.Arch Ophthalmol,102,1130-1134.
2. (2001).Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years.Arch Ophthalmol,119,1110-1118.
3. (2005).The International Classification of Retinopathy of Prematurity revisited.Arch Ophthalmol,123,991-999.
4. Baumal, CR,Goldberg, RA,Fein, JG(2015).Primary intravitreal ranibizumab for high-risk retinopathy of prematurity.Ophthalmic Surg Lasers Imaging Retina,46,432-438.
5. Capone, A, Jr,Trese, MT(2001).Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments.Ophthalmology,108,2068-2070.
6. Chen, SN,Lian, I,Hwang, YC(2015).Intravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between Ranibizumab and Bevacizumab.Retina,35,667-674.
7. Chen, W,Binenbaum, G,Karp, K(2014).Late recurrence of retinopathy of prematurity after treatment with both intravitreal bevacizumab and laser.JAAPOS,18,402-404.
8. Connolly, BP,McNamara, JA,Sharma, S(1998).A comparison of laser photocoagulation with trans-scleral cryotherapy in the treatment of threshold retinopathy of prematurity.Ophthalmology,105,1628-1631.
9. Day, S,Menke, AM,Abbott, RL(2009).Retinopathy of prematurity malpractice claims: the Ophthalmic Mutual Insurance Company experience.Arch Ophthalmol,127,794-798.
10. Fierson, WM(2013).Screening examination of premature infants for retinopathy of prematurity.Pediatrics,131,189-195.
11. Good, WV,Hardy, RJ(2001).The multicenter study of Early Treatment for Retinopathy of Prematurity (ETROP).Ophthalmology,108,1013-1014.
12. Hu, J,Blair, MP,Shapiro, MJ(2012).Reactivation of retinopathy of prematurity after bevacizumab injection.Arch Ophthalmol,130,1000-1006.
13. Hwang, CK,Hubbard, GB,Hutchinson, AK(2015).Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.Ophthalmology,122,1008-1015.
14. Isaac, M,Mireskandari, K,Tehrani, N(2015).Treatment of type 1 retinopathy of prematurity with bevacizumab versus laser.JAAPOS,19,140-144.
15. Lambert, SR,Capone, A, Jr(1996).Visual acuity of eyes after vitrectomy for ROP.Ophthalmology,103,1331-1332.
16. Mehta, S,Hubbard, GB, 3rd(2013).Delayed recurrent neovascularization and persistent avascular retina following intravitreal bevacizumab for retinopathy of prematurity.Retin Cases Brief Reports,7,206-209.
17. Menke, MN,Framme, C,Nelle, M(2015).Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease.BMC Ophthalmol,15,20.
18. Mintz-Hittner, HA,Kennedy, KA,Chuang, AZ(2011).Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.N Engl J Med,364,603-615.
19. Palmer, EA(1990).Results of U.S. randomized clinical trial of cryotherapy for ROP (CRYO-ROP).Doc Ophthalmol,74,245-251.
20. Stenson, BJ,Tarnow-Mordi, WO,Darlow, BA(2013).Oxygen saturation and outcomes in preterm infants.N Engl J Med,368,2094-2104.
21. Wong, RK,Hubschman, S,Tsui, I(2015).Reactivation of retinopathy of prematurity after ranibizumab treatment.Retina,35,675-680.

1. (2023)。一位早產兒視網膜病變之護理經驗。長庚護理，34(增訂刊2)，1-11。